Provided by Tiger Fintech (Singapore) Pte. Ltd.

Disc Medicine

89.94
+15.5820.95%
Post-market: 90.000.0750+0.08%19:54 EDT
Volume:2.26M
Turnover:204.77M
Market Cap:3.13B
PE:-19.85
High:95.95
Open:85.50
Low:83.88
Close:74.36
52wk High:95.95
52wk Low:30.82
Shares:34.77M
Float Shares:28.68M
Volume Ratio:6.33
T/O Rate:7.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5319
EPS(LYR):-3.9613
ROE:-26.36%
ROA:-17.95%
PB:5.09
PE(LYR):-22.70

Loading ...

Disc Medicine Director Cashes In on Major Stock Sale!

TIPRANKS
·
Yesterday

Disc Medicine Inc. Director Kevin Bitterman Reports Disposal of Common Shares

Reuters
·
Yesterday

Disc Medicine's Bitopertin Could See US FDA Approval by Early February 2026, Wedbush Says

MT Newswires Live
·
Yesterday

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday

Benzinga_recent_news
·
Yesterday

Leerink Partners Keeps Their Buy Rating on Disc Medicine (IRON)

TIPRANKS
·
Oct 17

Disc Medicine Up Nearly 23%, On Pace For Largest Percent Increase Since November 2024 -- Data Talk

Dow Jones
·
Oct 17

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

Benzinga_recent_news
·
Oct 17

Disc Medicine rises 25.5%

TIPRANKS
·
Oct 17

Shares of Some US Drug Developers up After FDA Announces Recipients of National Priority Vouchers

THOMSON REUTERS
·
Oct 17

Revolution Medicines up 6%, Achieve Life Sciences up 22.1%, Disc Medicine up 19.2%

THOMSON REUTERS
·
Oct 17

Sector Update: Health Care Stocks Mixed Premarket Friday

MT Newswires Live
·
Oct 17

Cantor Fitzgerald Sticks to Their Buy Rating for Disc Medicine (IRON)

TIPRANKS
·
Oct 17

Disc Medicine to Present Phase 1b Trial Data of DISC-0974 for Anemia in CKD Patients at 2025 ASN Kidney Week

Reuters
·
Oct 17

Disc Medicine Is Maintained at Outperform by Wedbush

Dow Jones
·
Oct 17

Wedbush Adjusts Price Target on Disc Medicine to $110 From $90, Maintains Outperform Rating

MT Newswires Live
·
Oct 17

Disc Medicine price target raised to $110 from $90 at Wedbush

TIPRANKS
·
Oct 17

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM) and Disc Medicine (IRON)

TIPRANKS
·
Oct 17

24H|Disc Medicine Surged 19%; Praxis Precision Rose 7%; Rare Earth Stocks Kept Dropping. UAMY And USA Rare Earth Fell 7%

Tiger Newspress
·
Oct 17

Disc Medicine Gets FDA Commissioner's National Priority Voucher for Drug Candidate

MT Newswires Live
·
Oct 17

Disc Medicine receives CNPV from FDA for Bitopertin

TIPRANKS
·
Oct 17